A compound with the SMILES Clc1ccc2c(c1)-c1nnc(Br)n1-c1ccccc1S2 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 0.703\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Clc1ccc2c(c1)-c1nnc(Br)n1-c1ccccc1S2
Clc1ccc2c(c1)-c1nnc(Br)n1-c1ccccc1S2
3-bromo-9-chloro-13-thia-2,4,5-triazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,5,7(12),8,10,14,16-octaene